Skip to search formSkip to main contentSkip to account menu

Anticoagulants

Known as: Anticoagulant Agent, thrombopoiesis inhibitor, anticoagulant drug 
A substance that is used to prevent and treat blood clots in blood vessels and the heart.
National Institutes of Health

Related topics

Related topics

48 relations

Narrower (37)

0.2 ML Dalteparin Sodium 25000 UNT/ML Prefilled Syringe5 ML heparin sodium, porcine 10 UNT/ML Prefilled SyringeAncrodCitric Acid
Anticoagulation TherapyAntithrombinsBlood Platelet DisordersBlood coagulation

Broader (1)

Pharmaceutical Preparations

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
Summary The new anticoagulants dabigatran and rivaroxaban can be responsible for haemorrhagic complications. As for any… 
Review
2012
Review
2012
Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians…
BACKGROUND To develop the Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: ACCP Evidence-Based Clinical Practice… 
Highly Cited
2008
Highly Cited
2008
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
This chapter describes the pharmacology of approved parenteral anticoagulants, including the indirect anticoagulants… 
Highly Cited
2008
Highly Cited
2008
Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy
Background: Whether to continue oral anticoagulant therapy beyond 6 months after an “unprovoked” venous thromboembolism is… 
Highly Cited
2005
Highly Cited
2005
Impact of bleeding severity on clinical outcomes among patients with acute coronary syndromes.
Highly Cited
1999
Highly Cited
1999
In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.
Microparticles (MPs) resulting from vesiculation of platelets and other blood cells have been extensively documented in vitro and… 
Review
1997
Review
1997
Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes.
THE KALLIKREIN-KININ system was first recognized as a plasma and tissue proteolytic system responsible for the liberation of the… 
Review
1991
Review
1991
Oral anticoagulant drugs.
The vitamin K-antagonist drugs were reviewed in the Journal in the early 1970s.1 , 2 Since then, there has been considerable… 
Highly Cited
1983
Highly Cited
1983
Thrombosis, abortion, cerebral disease, and the lupus anticoagulant.
employment the occupational medical officer should also be notified. Few diabetics register on the Disabled Persons Register, but… 
Highly Cited
1980
Highly Cited
1980
Reconstructive surgery of mitral valve incompetence: ten-year appraisal.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)